2,3,7,8-Tetrachlorodibenzo-p-dioxin
CASRN 1746-01-6 | DTXSID2021315
- IRIS Summary (PDF) (16 pp, 146.5 KB)
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin Support Documents
EPA's Reanalysis of Key Issues Related to Dioxin Toxicity and Response to NAS Comments (Volume 1) (Interagency Science Discussion Draft)
Notice - This site contains archived material(s)
Archive disclaimer
Archived files are provided for reference purposes only.
The file was current when produced, but is no longer maintained and may now be outdated.
Persons with disabilities having difficulty accessing archived files may contact the Risk Webmaster for assistance.
Please use the contact us form if you need additional support.
Overview
Citation
Background
History/Chronology
Date | Description |
---|---|
Feb 2010 | EPA initiated an interagency science consultation on the review of the draft Response to "Health Risks from Dioxin and Related Compounds: Evaluation of the EPA Reassessment" published by the NRC/NAS . |
May 2010 | EPA released the EPA's Reanalysis of Key Issues Related to Dioxin Toxicity and Response to NAS Comments (External Review Draft) for public comment. [Federal Register May 21, 2010] |
Jun 2010 | EPA extended the public comment period until September 20, 2010. [Federal Register Notice Jun 23, 2010] |
Oct 2011 | EPA initiated an interagency science discussion on the review of the draft final "Reanalysis of Key Issues Related to Dioxin Toxicity and Response to NAS Comments, Volume 1". |
Feb 2012 | EPA released the final dioxin reanalysis report and IRIS Summary for 2,3,7,8-Tetrachlorodibenzo-P-Dioxin (TCDD), along with the interagency science discussion draft, interagency comments, and EPA's response to major interagency comments. |
Status
Download(s)
This download(s) is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy.
- EPA’s Reanalysis of Key Issues Related to Dioxin Toxicity and Response to NAS Comments, Volume 1 (Interagency Science Discussion) (PDF) (356 pp, 3.4 MB, about PDF)
- Dioxin Reanalysis, Volume 1, Appendices: A -- I (Interagency Science Discussion) (PDF) (1577 pp, 13.3 MB, about PDF)
- IRIS Summary for Dioxin (Interagency Science Discussion) (PDF) (13 pp, 141.6 KB, about PDF)
- EPA’s Response to Major Interagency Comments on the Interagency Science Discussion Draft of the Dioxin Reanalysis, Volume 1 (PDF) (10 pp, 404.3 KB, about PDF)
- 1. CDC ATSDR Comments on the Dioxin Reanalysis Vol 1 -- IASD Draft (PDF) (2 pp, 115.2 KB, about PDF)
- 2. CEQ Comments on the Dioxin Reanalysis Vol 1 -- IASD Draft (ZIP) (6.0 MB, about ZIP)
- 3. DoD Office of the Deputy Under Secretary of Defense (Installations & Environment) Comments on the Dioxin Reanalysis Vol 1 -- IASD Draft (PDF) (19 pp, 351.6 KB, about PDF)
- 4. NASA EMD HQ Comments on the Dioxin Reanalysis Vol 1 -- IASD Draft (PDF) (3 pp, 455.1 KB, about PDF)
- 5. NIEHS NTP Comments on the Dioxin Reanalysis Vol 1 -- IASD Draft (PDF) (2 pp, 187.5 KB, about PDF)
- 6. USDA OBPA Comments on the Dioxin Reanalysis Vol 1 -- IASD Draft (PDF) (1 pp, 29.3 KB, about PDF)
If you have a disability and the format of any material on our web pages interferes with your ability to access the information, please reach out to us using the Contact Us about IRIS form for assistance. To enable us to respond in a manner most helpful to you, please indicate the nature of the accessibility problem, the web address of the requested material, your preferred format in which you want to receive the material (electronic format (ASCII, etc.), standard print, large print, etc.), and your contact information.
Document Related Link(s)
- EPA's Response to Health Risks from Dioxin and Related Compounds Evaluation of the EPA Reassessment Published by the National Research Council of the National Academies (Interagency Science Consultation Draft)
- EPA's Reanalysis of Key Issues Related to Dioxin Toxicity and Response to NAS Comments (External Review Draft)